Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease [dataset3]
Single-cell RNA-seq · human · 32 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 32 samples: 32 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's diseaseNature medicine · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE263079_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1095549 and SRA study SRP499392. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 32 sample titles: 32 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8185212 nAD3-fcx-mRNA
- GSM8185213 nAD3-tcx-mRNA
- GSM8185214 nAD3-pcx-mRNA
- GSM8185215 nAD3-hipp-mRNA
- GSM8185216 LCMB-fcx-mRNA
- GSM8185217 LCMB-tcx-mRNA
- GSM8185218 LCMB-pcx-mRNA
- GSM8185219 LCMB-hipp-mRNA
- GSM8185220 nAD3-fcx-PRO
- GSM8185221 nAD3-tcx-PRO
- GSM8185222 nAD3-pcx-PRO
- GSM8185223 nAD3-hipp-PRO
- GSM8185224 LCMB-fcx-PRO
- GSM8185225 LCMB-tcx-PRO
- GSM8185226 LCMB-pcx-PRO
- GSM8185227 LCMB-hipp-PRO
- GSM8675576 nAD2-fcx-mRNA
- GSM8675577 nAD2-tcx-mRNA
- GSM8675578 nAD2-pcx-mRNA
- GSM8675579 nAD2-hipp-mRNA
- GSM8675580 nAD1-fcx-mRNA
- GSM8675581 nAD1-tcx-mRNA
- GSM8675582 nAD1-pcx-mRNA
- GSM8675583 nAD1-hipp-mRNA
- GSM8675584 nAD2-fcx-PRO
- GSM8675585 nAD2-tcx-PRO
- GSM8675586 nAD2-pcx-PRO
- GSM8675587 nAD2-hipp-PRO
- GSM8675588 nAD1-fcx-PRO
- GSM8675589 nAD1-tcx-PRO
- GSM8675590 nAD1-pcx-PRO
- GSM8675591 nAD1-hipp-PRO
- GSE263038 Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease [dataset2] 3 samples shares microglial, clearance, immunized, alzheimer, amyloid, drive
- GSE323984 MEF2C controls lysosomal and lipid clearance programs linked to Alzheimer’s disease risk in macrophages [bulkRNAseq_WTC11_iMGL] 48 samples shares clearance, alzheimer
- GSE323982 MEF2C controls lysosomal and lipid clearance programs linked to Alzheimer’s disease risk in macrophagesm [scRNAseq_WTC11_iMGL_ReN] 16 samples shares clearance, alzheimer
- GSE324006 MEF2C controls lysosomal and lipid clearance programs linked to Alzheimer’s disease risk in macrophages [scRNA-seq] 16 samples shares clearance, alzheimer
- GSE267554 Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer’s disease 16 samples shares clearance, alzheimer
- GSE308813 Alzheimer's disease-associated PLCG2 variants alter microglial state and function in human iPSC-derived microglia-like cells 16 samples shares microglial, alzheimer
- GSE255538 PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease 15 samples shares microglial, alzheimer
- GSE226507 Systematic characterization of brain cellular crosstalk reveals a novel role for SEMA6D in TREM2-associated microglial function in Alzheimer’s disease 12 samples shares microglial, alzheimer
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.